e-learning
resources
Vienna 2003
Wednesday 01.10.2003
Outcome of acute exacerbations in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB)
G. B. Diette, C. B. Cangialose, T. G. Knight, Y. C. Yeh, T. F. Goss, J. P. Harnett, J. Wilson (Baltimore, Gaithersburg, New York)
Source:
Annual Congress 2003 - Outcome of acute exacerbations in COPD
Session:
Outcome of acute exacerbations in COPD
Session type:
Oral Presentation
Number:
3522
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. B. Diette, C. B. Cangialose, T. G. Knight, Y. C. Yeh, T. F. Goss, J. P. Harnett, J. Wilson (Baltimore, Gaithersburg, New York). Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB). Eur Respir J 2003; 22: Suppl. 45, 3522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 928-933
Year: 2001
Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity
Source: Eur Respir J 2002; 20: Suppl. 38, 545s
Year: 2002
Correlation between eradication of infecting organism on days 3-5 of antibiotic therapy and clinical cure in patients with acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019
Efficacy of levofloxacin (LVF) in the treatment of acute exacerbations of chronic bronchitis (AECB) in patients with risk factors
Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD
Year: 2003
Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations
Source: Eur Respir Rev 2006; 15: 47-51
Year: 2006
Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions
Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018
Year: 2019
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Effects on health care utilisation of early pulmonary rehabilitation on hospitalisation for an acute exacerbation of chronic respiratory disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Factors associated with higher direct costs of exacerbations of chronic bronchitis and COPD in primay care
Source: Eur Respir J 2004; 24: Suppl. 48, 410s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept